Dr. Smita Jain | Drug Science Awards | Best Researcher Award

Dr. Smita Jain, Central University of Rajasthan, India

Dr. Smita Jain is an Assistant Professor (Contractual) in the Department of Pharmacy at the Central University of Rajasthan, where she specializes in pharmacology. She holds a Ph.D. from Banasthali Vidyapith, focusing on the discovery of novel fatty acid amide hydrolase (FAAH) inhibitors through pharmacophore-based virtual screening, molecular docking, and biological evaluation. With a cumulative impact factor of 95 and 276 citations, Dr. Jain has made significant contributions to neuropharmacology, molecular pharmacology, and computer-aided drug design. Her research interests include the pharmacological evaluation of both natural and synthetic compounds in rodent models for various health conditions, including diabetes, hypertension, and neurodegenerative diseases. Dr. Jain is proficient in statistical analysis, scientific writing, and data retrieval from major academic portals. She has a strong background in cell-based assays, toxicity studies, and biochemical evaluations, contributing to her reputation as a skilled researcher and educator in the field of pharmacology.

Professional Profile:

SCOPUS

Research for Best Researcher Award: Dr. Smita Jain

Overview: Dr. Smita Jain is an exemplary candidate for the Best Researcher Award, showcasing a strong academic and research background in the field of pharmacology. With a Ph.D. from Banasthali Vidyapith and current employment as an Assistant Professor at the Central University of Rajasthan, Dr. Jain has made significant contributions to neuropharmacology, molecular pharmacology, and computer-aided drug design.

Education

Ph.D. in Pharmacology
- Institution: Banasthali Vidyapith, Banasthali, India
- Duration: 2018-2023
- Thesis Title: Discovery of Novel Fatty Acid Amide Hydrolase (FAAH) Inhibitors through Sequential Application of Pharmacophore-based Virtual Screening, Molecular Docking, and Biological Evaluation
- Research Supervisors:
  - Dr. Swapnil Sharma, Associate Professor
  - Prof. Sarvesh Paliwal, Dean (Instruction), Head, Department of Pharmacy
Master in Pharmacy (Pharmacology)
- Institution: Banasthali Vidyapith, Banasthali, India
- Duration: 2016-2018
- CGPA: 8.57
- Dissertation Title: Anti-Alzheimer Activity of Test Compounds BVSJ-03 and BVSJ-04 in Experimental Rodents
- Research Supervisor: Dr. Swapnil Sharma, Associate Professor
Bachelor in Pharmacy
- Institution: Banasthali Vidyapith, Banasthali, India
- Duration: 2012-2016
- Percentage: 78%

Work Experience

Assistant Professor (Contractual)
- Department: Department of Pharmacy, School of Chemical Sciences and Pharmacy
- Institution: Central University of Rajasthan, Kishangarh, Rajasthan, India
- Duration: 2023 – Present
- Responsibilities: Teaching, research, and scientific writing.
Junior Research Fellow
- Funding: DST-SERB, New Delhi
- Department: Tissue Culture Lab, Department of Bioscience and Biotechnology
- Institution: Banasthali Vidyapith, Banasthali, India
- Duration: 2020-2022

Publication top Notes:

Identification of new triazolo annulated dipyridodiazepine derivatives as HIV-1 reverse transcriptase inhibitors: Design, synthesis, DFT, molecular modelling and in silico studies

BACE1 inhibitors: A promising therapeutic approach for the management of Alzheimer’s disease

Association Between Type 2 Diabetes Mellitus and Alzheimer’s Disease: Common Molecular Mechanism and Therapeutic Targets

Airways Relaxant and Antiasthmatic Activity of Aconitum heterophyllum Wall ex Royle. Roots: A Mechanistic Insight

Elucidating the therapeutic mechanism of betanin in Alzheimer’s Disease treatment through network pharmacology and bioinformatics analysis

Prof Dr. Nuri Faruk Aykan, Istinye University, Turkey

N. Faruk Aykan, born in 1953 in Kahramanmaraş, Turkey, is a distinguished Professor of Medical Oncology at Istinye University Medical School in Istanbul. He earned his medical degree and specialty in Internal Medicine from Ankara University Medical School in 1976 and 1981, respectively, and later became a Medical Oncologist at Istanbul University’s Institute of Oncology in 1991. Prof. Aykan’s primary research focus is on gastrointestinal cancers, with additional training in Paris under Prof. J-P Marie at Hotel-Dieu in 1991. He has contributed to numerous international clinical trials, including PETACC-1, CRYSTAL, RADIANT-2, and others. A member of prominent organizations such as ASCO, ESMO, and the Medical Oncology Association of Turkey, Prof. Aykan has published 58 scientific papers, 28 textbook chapters, and 128 abstracts in multiple languages. His H-index is 20, with 5,741 citations as of May 2024. He also serves on the editorial boards of journals like the World Journal of Gastrointestinal Oncology and Turkish Journal of Cancer. Additionally, Prof. Aykan has a notable interest in theoretical biology, particularly intercellular communication, and has been recognized with awards such as the 2013 Turkish Cancer Research Prize for his work on the KOLONTURK trial.

Summary of Suitability for Best Researcher Award:

Prof. N. Faruk Aykan’s distinguished career in medical oncology, particularly focusing on gastrointestinal cancers, positions him as a strong contender for the Best Researcher Award. His extensive clinical and research background, complemented by his participation in several international trials, such as PETACC-1, Pfizer SUTENT, and CRYSTAL, highlights his global impact in oncology.

Education

1976: Medical Degree, Ankara University Medical School, Ankara, Turkey

1981: Specialty in Internal Medicine, Ankara University Medical School, Ankara, Turkey

1991: Medical Oncology Training, Istanbul University, Institute of Oncology, Istanbul, Turkey

1991: Medical Oncology Training, Hotel-Dieu, Paris, France (under Pr. J-P Marie)

Work Experience

Current Position: Professor of Medical Oncology, Istinye University Medical School, Department of Medical Oncology, Istanbul, Turkey

1991–Present: Medical Oncologist, Istanbul University, Institute of Oncology, Istanbul, Turkey

1991: Medical Oncology Training, Hotel-Dieu, Paris, France

Participated in international clinical trials, including PETACC-1, CPT-CMA 202, Aventis V-306, V-307, Pfizer SUTENT, CRYSTAL, RADIANT-2, CORRECT, RILOMET, REGARD, Roche MODUL, and Servier PRECONNECT trials.

Publication top Notes: